Curium Announces Revised Pricing for Technescan MAG3TM
04 sept. 2019 08h30 HE
|
Curium
St. Louis, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Curium announced today that it is implementing a new pricing model for Technescan MAG3. Curium is phasing out its pay per dose sales model, in which...
Telix Pharmaceuticals and Grupo RPH Sign LATAM Manufacturing and Distribution Agreement
02 juil. 2019 20h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and PORTO ALEGRE, Brazil, July 03, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
Telix Pharmaceuticals e Grupo RPH firmam Contrato de Manufatura e Distribuição para a LATAM
02 juil. 2019 20h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX.TLX) ( “Telix”, a “Empresa”), uma empresa biofarmacêutica de fase clínica...
Telix Pharmaceuticals y Grupo RPH firman acuerdo de fabricación y distribución en América Latina
02 juil. 2019 20h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia y PORTO ALEGRE, Brasil, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, la “Compañía”), una compañía biofarmacéutica en fase-clínica,...
RENNOVA HEALTH’S BIG SOUTH FORK MEDICAL CENTER, TN, COMPLETES INSTALLATION OF GE 64 SLICE CT SCANNER
27 août 2018 09h20 HE
|
Rennova Health, Inc.
WEST PALM BEACH, Fla, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”) a vertically integrated provider of industry-leading diagnostics...
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
29 mai 2018 19h00 HE
|
Telix Pharmaceuticals Limited
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Us Nuclear Corp to Become Miftec’s Exclusive Manufacturer of New Medical Isotope Generators
07 déc. 2017 13h25 HE
|
US Nuclear Corp.
LOS ANGELES, CA, Dec. 07, 2017 (GLOBE NEWSWIRE) -- US Nuclear Corp (OTCBB: UCLE) has signed a letter of intent with MIFTEC to become the exclusive contractor to manufacture medical isotope...
Radiopharmaceutical Regional Markets to See Double-Digit Growths, Reports BCC Research
26 janv. 2017 05h00 HE
|
BCC Research
Wellesley, Mass, Jan. 26, 2017 (GLOBE NEWSWIRE) -- A growing and aging population, increasing life expectancy, and improved diagnostic modalities are key factors in market growth for...